ClinicalTrials.gg
Sign In

DrugBiological

Samalizumab clinical trials

Also written ALXN6000.

studies test it
3
open now
1
in phase 3
1
first study started
2008

Keep track of what changes. Save the samalizumab studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Samalizumab
2

Development codes

ALXN6000
2

Studies by the year they started

3 studies that test it; most in 2016 (2)

Studies that test samalizumab, by start year
YearStudies
20081
20162

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
2
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it.

Leukemia, Lymphocytic, Chronic, B-Cell
1

Who runs them

Industry 2 · Other 1

Alexion Pharmaceuticals, Inc. (2) · Beat AML, LLC (1)

Often tested with

Tested in the same studies.

BI 836858 (1) · Daunorubicin (1) · Cytarabine (1) · Azacitidine (1) · Enasidenib (1) · Entospletinib (1) · Decitabine (1) · Pevonedistat (1)

Studies

Open first, then newest update. How each study uses samalizumab is read from its arms, and is right about nine times in ten.

Testing it · 3

Codes

What other systems call samalizumab · ClinicalTrials.gg INT001396

  • MeSH (NLM) C000709706samalizumabOne source NLM
  • UNII (FDA) 64EUX713G6SAMALIZUMABConfirmed FDA, NLM, Wikidata
  • Wikidata Q7408522samalizumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C77891SamalizumabOne source FDA
  • DrugBank DB12636One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.